Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

Jicheng Lv(Ministry of Education of the People's Republic of China), Vlado Perkovic(New South Wales Department of Health), Mark Woodward(UNSW Sydney), John Chalmers(UNSW Sydney), Bruce Neal(UNSW Sydney), Graham S. Hillis(The University of Western Australia), Toshiharu Ninomiya(The University of Sydney), Anthony Rodgers(The George Institute for Global Health), Fiona Turnbull(University of Sydney), Stephen MacMahon
PLoS Medicine
August 21, 2012
10.1371/journal.pmed.1001293
Cited by 779

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k